EDIT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Editas Medicine Inc

Watchlist Manager

Watchlist

Price: 3.115 USD 5.95% Market Closed

Market Cap: $522.7m

	Editas Medicine Inc NASDAQ:EDIT	US
B	Bien Sparebank ASA OSE:BIEN	NO
	ECS Botanics Holdings Ltd ASX:ECS	AU
	Premier Health of America Inc XTSX:PHA	CA
A	Altona Rare Earths PLC LSE:REE	UK
	Alaska Energy Metals Corp OTC:AKEMF	CA
	Compagnie de Saint Gobain SA OTC:CODGF	FR

Profitability Summary

Editas Medicine Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-178%

Negative 3Y Average Operating Margin

-388%

Operating Margin is Increasing

-1 118% > -178%

Negative Net Margin

-157%

Negative 3Y Average Net Margin

-430%

Net Margin is Increasing

-1 065% > -157%

Negative Free Cash Flow Margin

-256%

Negative 3Y Average Free Cash Flow Margin

-402%

Free Cash Flow Margin is Increasing

-876% > -256%

Negative ROE

-119%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-227%

Declining ROIC

-193% > -360%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.